{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:47:08Z","timestamp":1770770828910,"version":"3.50.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.yrtph.2013.12.008","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T09:48:21Z","timestamp":1388742501000},"page":"193-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Current concepts on integrative safety assessment of active substances of botanical, mineral or chemical origin in homeopathic medicinal products within the European regulatory framework"],"prefix":"10.1016","volume":"68","author":[{"given":"Marie-Luise","family":"Buchholzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Knoess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.yrtph.2013.12.008_b0005","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/S0031-9422(00)98092-0","article-title":"Eight 1,4-naphthoquinones from Juglans","volume":"28","author":"Binder","year":"1989","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.yrtph.2013.12.008_b0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2146\/ajhp050105","article-title":"Regulation of homeopathic drug products","volume":"63","author":"Borneman","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.yrtph.2013.12.008_b0015","unstructured":"Briggs , J.P., 2012. Complementary, Alternative, and Integrative Medicine. Chapter e2. In D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo (Eds.), Harrison\u2019s Principles of Internal Medicine, 18e. Retrieved November 26, 2013 from <http:\/\/www.accessmedicine.com\/content.aspx?aID=9106834>."},{"key":"10.1016\/j.yrtph.2013.12.008_b0020","unstructured":"Directive 2001\/83\/EC, Directive of the European parliament and of the council of 6 November 2001 on the community code relating to medicinal products for human use, OJ Official Journal L-311, 28\/11\/2004, 67."},{"key":"10.1016\/j.yrtph.2013.12.008_b0025","unstructured":"Directive 92\/73\/EEC, Council Directive of 22 September 1992 widening the scope of Directives 65\/65\/EEC and 75\/319\/EEC on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to medicinal products and laying down additional provisions on homeopathic medicinal products."},{"key":"10.1016\/j.yrtph.2013.12.008_b0030","unstructured":"EC Directive 95\/2\/EC, European parliament and council directive of 20 February 1995 on food additives other than colours and sweeteners."},{"key":"10.1016\/j.yrtph.2013.12.008_b0035","first-page":"1","article-title":"Opinion of the Scientific Panel on Contaminants in the Food chain on a request from the European Commission to perform a scientific risk assessment on nitrate in vegetables","volume":"689","author":"EFSA","year":"2008","journal-title":"J. No."},{"key":"10.1016\/j.yrtph.2013.12.008_b0040","first-page":"1","article-title":"Safety of aluminium from dietary intake, Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Food Contact Materials (AFC)","volume":"754","author":"EFSA","year":"2008","journal-title":"EFSA J."},{"issue":"7","key":"10.1016\/j.yrtph.2013.12.008_b0045","first-page":"103","article-title":"Scientific opinion on exploring options for providing advice about possible human health risks based on the concept of Threshold of Toxicological Concern (TTC)","volume":"10","author":"EFSA","year":"2012","journal-title":"EFSA J."},{"key":"10.1016\/j.yrtph.2013.12.008_b0050","unstructured":"EMEA, 2006. Guideline on the Limits of Genotoxic impurities. CPMP\/SWP\/5199\/02, EMEA\/CHMP\/QWP\/251344\/2006."},{"key":"10.1016\/j.yrtph.2013.12.008_b0055","unstructured":"EMEA, 2008a. Guideline on the Specification Limits for Residues of Metal Catalysts or Metal Reagents, 21 February 2008, EMEA\/CHMP\/SWP\/4446\/2000."},{"key":"10.1016\/j.yrtph.2013.12.008_b0060","unstructured":"EMEA, 2008b. Committee on Herbal Medicinal Products (HMPC). Guideline on the assessment of genotoxicity of herbal substances\/preparations, EMEA\/HMPC\/107079\/2007."},{"key":"10.1016\/j.yrtph.2013.12.008_b0065","unstructured":"FAO\/WHO, 2003a. Food and Agriculture Organisation of the United Nations\/World Health Organization. Nitrate (and potential endogenous formation of N-nitroso compounds). World Health Organisation WHO Food Additive series 50."},{"key":"10.1016\/j.yrtph.2013.12.008_b0070","unstructured":"FAO\/WHO, 2003b. Food and Agriculture Organisation of the United Nations\/World Health Organization. Nitrite (and potential endogenous formation of N-nitroso compounds). World Health Organisation WHO Food Additive series 50."},{"key":"10.1016\/j.yrtph.2013.12.008_b0075","first-page":"36582","article-title":"Food additives: threshold of regulation for substances used in food-contact articles. Final rule","volume":"60","author":"FDA","year":"1995","journal-title":"Fed. Reg."},{"key":"10.1016\/j.yrtph.2013.12.008_b0080","unstructured":"German Additives Regulation ZZulV, 1998. Zusatzstoff-Zulassungs-VO Anlage 5, Teil C Andere Konservierungsstoffe, Liste 1: Nitrite und Nitrate."},{"key":"10.1016\/j.yrtph.2013.12.008_b0085","unstructured":"HagerROM 2008. Hagers Enzyklop\u00e4die der Arzneistoffe und Drogen."},{"key":"10.1016\/j.yrtph.2013.12.008_b0090","unstructured":"Introduction to the List of First Safe Dilutions, adoption by Heads of Medicines Agencies (HMA) in 2010, prepared by the Homeopathic Medicinal Products Working Group (HMPWG)."},{"key":"10.1016\/j.yrtph.2013.12.008_b0095","unstructured":"ICH Guideline Q3C (R5) on Impurities: Guideline for residual solvents, EMA\/CHMP\/ICH\/82260\/2006."},{"key":"10.1016\/j.yrtph.2013.12.008_b0100","unstructured":"ICH Guideline M7 (Step 3) on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk, May 2013, EMA\/CHMP\/ICH\/83812\/2013."},{"issue":"3","key":"10.1016\/j.yrtph.2013.12.008_b0105","first-page":"323","article-title":"Determination of juglone from leaves and fresh peels of Juglans regia L. by high performance liquid chromatography","volume":"20","author":"Kamkar","year":"2004","journal-title":"Iranian J. Med. Aromatic Plants Res."},{"key":"10.1016\/j.yrtph.2013.12.008_b0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-6915(99)00120-9","article-title":"Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing","volume":"38","author":"Kroes","year":"2000","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2013.12.008_b0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.fct.2003.08.006","article-title":"Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet","volume":"42","author":"Kroes","year":"2004","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2013.12.008_b0120","unstructured":"Merck Manual, 2004\u20132012, The Merck Manual Online, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc, Whitehouse Station, N.J., U.S.A., Robert S. Porter, MD, Justin L. Kaplan, MD."},{"key":"10.1016\/j.yrtph.2013.12.008_b0125","unstructured":"PtC, Points to Consider on Non-Clinical Safety of Homeopathic Medicinal Products of Botanical, Mineral and Chemical Origin, adoption by HMA in July 2007."},{"key":"10.1016\/j.yrtph.2013.12.008_b0130","unstructured":"NTP, Summary of data for chemical selection \u2013 Plumbagin, 481-42-5, Summary of data for chemical selection \u2013 Juglone, 481-39-0, of the Summary of data for chemical selection, 1999."},{"key":"10.1016\/j.yrtph.2013.12.008_b0135","unstructured":"Ph. Eur., Monograph 1038, European Pharmacopoeia Monograph \u201cHomeopathic Preparations\u201d, 1995."},{"issue":"1","key":"10.1016\/j.yrtph.2013.12.008_b0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yrtph.2013.03.004","article-title":"Feasibility study of nonclinical safety assessments on homeopathic preparations using the example of protoanemonin in Pulsatilla pratensis L.","volume":"66","author":"Schrenk","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2013.12.008_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yrtph.2013.05.001","article-title":"Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities","volume":"67","author":"Sutter","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2013.12.008_b0150","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2009.08.022","article-title":"In silico toxicology for the pharmaceutical sciences","volume":"241","author":"Valerio","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2013.12.008_b0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1479-7364-5-3-200","article-title":"In silico toxicology models and databases as FDA Critical Path Initiative toolkits","volume":"5","author":"Valerio","year":"2011","journal-title":"Hum. Gen."},{"key":"10.1016\/j.yrtph.2013.12.008_b0160","unstructured":"World Health Organization, WHO, 2009. Safety issues in the preparation of homeopathic medicines. Key technical issues of quality impacting on the safety of homeopathic medicines. WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. ISBN 978 92 4 159884 2."},{"issue":"5","key":"10.1016\/j.yrtph.2013.12.008_b0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/026119290903700509","article-title":"Computational toxicology approaches at the US Food and Drug Administration","volume":"37","author":"Yang","year":"2009","journal-title":"Altern. Lab. Anim."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230013002237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230013002237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:42:38Z","timestamp":1565034158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230013002237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0273230013002237"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2013.12.008","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current concepts on integrative safety assessment of active substances of botanical, mineral or chemical origin in homeopathic medicinal products within the European regulatory framework","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2013.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}